AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Suglow G 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

BRD MediLabs

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Suglow G 1mg/500mg Tablet

Diabexe Duo 1mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Diabexe Duo with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, manifesting as sweating, dizziness, headache, or tremors. Regular meals and readily available glucose sources (e.g., sugary foods, juice) are essential. Alcohol consumption increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Inform your doctor of any prior heart conditions before starting treatment; it may be unsuitable. Pregnant or lactating individuals should consult their physician before use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Primary Ingredients of Suglow G 1mg/500mg Tablet

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Suglow G 1mg/500mg Tablet

Managing Type 2 Diabetes

Major Benefits of Suglow G 1mg/500mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Suglow G 1mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.

Common Side effects of Suglow G 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Suglow G 1mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and schedule. Ingest the Suglow G 1mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

How Suglow G 1mg/500mg Tablet works:

Suglow G tablets (1mg glimepiride/500mg metformin) combine two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with Suglow G 1mg/500mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Suglow G 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescribing this medication. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Administering Suglow G 1mg/500mg tablets while breastfeeding is contraindicated. Available evidence indicates potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Suglow G 1mg/500mg tablets, as dosage modification may be necessary. For those with severe kidney disease, this medication is contraindicated. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Suglow G 1mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician. For individuals with mild to moderate hepatic dysfunction, initiate treatment with a reduced Suglow G 1mg/500mg tablet dosage; this medication is contraindicated in those with severe liver disease.

What if you forget to take Suglow G 1mg/500mg Tablet :

Should you forget to take your Suglow G 1mg/500mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Suglow G 1mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Diabetes medication

FAQs on Suglow G 1mg/500mg Tablet

Retain this medication within its original, tightly sealed container or packaging. Observe the storage guidelines specified on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and other individuals.
Taking Suglow G 1mg/500mg tablets may result in lactic acidosis, a serious medical condition characterized by excessive lactic acid in the bloodstream. Also termed MALA (Metformin-associated lactic acidosis), this rare but potentially harmful side effect is more likely in individuals with kidney impairment, the elderly, or those who consume significant amounts of alcohol. Symptoms can include muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, and bradycardia. If these symptoms occur, discontinue Suglow G 1mg/500mg tablet use and seek immediate medical attention.
Suglow G, a 1mg/500mg tablet, combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when coupled with a suitable diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas, reducing blood glucose. Metformin reduces hepatic glucose production and increases insulin responsiveness. This formulation is unsuitable for type 1 diabetes mellitus.
Suglow G 1mg/500mg Tablet may cause common adverse reactions including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, and headache. Rare but potentially severe side effects such as lactic acidosis are also possible. Prolonged administration may result in vitamin B12 deficiency.
Prolonged consumption of Suglow G 1mg/500mg tablets can indeed lead to Vitamin B12 deficiency. This medication disrupts Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications such as paresthesia in the extremities, weakness, urinary dysfunction, cognitive impairment, and ataxia. Preventive measures, according to some studies, include supplemental Vitamin B12 intake at least annually.
Indeed, taking Suglow G 1mg/500mg tablets may lead to hypoglycemia (low blood glucose). Low blood sugar can manifest as nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. This risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. It's advisable to always carry a readily available fast-acting sugar source such as glucose tablets, honey, or fruit juice.
Combining Suglow G 1mg/500mg tablets and alcohol is unsafe. Concurrent use may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Suglow G 1mg/500mg Tablet
53
MRP 65
18% off